Safety and Pharmacokinetics of Once-Daily Regimens of Soft-Gel Capsule Saquinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Negative Adults

Human immunodeficiency virus type 1 (HIV-1) protease inhibitors have dramatically improved treatment options for HIV infection, but frequent dosing may impact adherence to highly active antiretroviral treatment regimens (HAART). Previous studies demonstrated that combined therapy with ritonavir and...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Kilby, J. Michael, Sfakianos, Greg, Gizzi, Nick, Siemon-Hryczyk, Peggy, Ehrensing, Eric, Oo, Charles, Buss, Neil, Saag, Michael S.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Pharmacology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90133/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10991842/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.10.2672-2678.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!